Angiodynamics (ANGO) Capital Expenditures (2010 - 2026)
Angiodynamics' (ANGO) quarterly Capital Expenditures came in at $413000.0 in Q2 2026, down 46.85% YoY from $777000.0 in Q2 2025, and down 59.31% on a QoQ basis from $1.0 million in Q1 2026.
Angiodynamics (ANGO) Capital Expenditures (2010 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 17 years of Capital Expenditures data on file, last reported at $413000.0 in Q2 2026.
- Quarterly Capital Expenditures fell 46.85% year-over-year to $413000.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $2.6 million (down 42.18% YoY) and the FY2026 annual result came in at $2.6 million, down 42.18% from the prior year.
- Capital Expenditures retreated to $413000.0 in Q2 2026, from $1.0 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $2.8 million in Q1 2023 to a low of -$1.1 million in Q2 2023.
- A 5-year average of $862222.2 and a median of $772000.0 in 2023 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 521.9% in 2023, down 206.83% in 2023.
- Tracing ANGO's Capital Expenditures over 5 years: stood at -$137000.0 in 2022, then jumped by 521.9% to $578000.0 in 2023, then jumped by 101.38% to $1.2 million in 2024, then sank by 63.75% to $422000.0 in 2025, then dropped by 2.13% to $413000.0 in 2026.
- The last three Capital Expenditures figures came in at $413000.0 (Q2 2026), $1.0 million (Q1 2026), and $422000.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.62 Bn | 129.40 Bn | 1.96 Bn | 112.60 Mn |
| 2 | Becton Dickinson | 52.57 Bn | 51.71 Bn | 2.32 Bn | 143.00 Mn |
| 3 | Alcon | 35.72 Bn | 34.36 Bn | 1.68 Bn | 374.00 Mn |
| 4 | Resmed | 33.78 Bn | 32.31 Bn | 861.22 Mn | 51.13 Mn |
| 5 | Medline | 29.07 Bn | 26.40 Bn | 2.22 Bn | 111.00 Mn |
| 6 | West Pharmaceutical Services | 24.97 Bn | 24.54 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Solventum | 15.39 Bn | 14.99 Bn | 1.29 Bn | 83.00 Mn |
| 8 | Cooper Companies | 14.82 Bn | 14.68 Bn | 735.40 Mn | 86.40 Mn |
| 9 | Baxter International | 13.60 Bn | 11.45 Bn | 1.03 Bn | 116.00 Mn |
| 10 | Angiodynamics | 651.54 Mn | 597.68 Mn | 46.77 Mn | 70,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 413,000.00 |
| May 31, 2026 | 413,000.00 |
| Feb 28, 2026 | 1.02 Mn |
| Feb 28, 2026 | 1.02 Mn |
| Nov 30, 2025 | 422,000.00 |
| Nov 30, 2025 | 422,000.00 |
| Aug 31, 2025 | 731,000.00 |
| Aug 31, 2025 | 731,000.00 |
| May 31, 2025 | 777,000.00 |
| May 31, 2025 | 777,000.00 |
| Feb 28, 2025 | 1.21 Mn |
| Feb 28, 2025 | 1.21 Mn |
| Nov 30, 2024 | 1.16 Mn |
| Nov 30, 2024 | 1.16 Mn |
| Aug 31, 2024 | 1.31 Mn |
| Aug 31, 2024 | 1.31 Mn |
| May 31, 2024 | 566,000.00 |
| May 31, 2024 | 566,000.00 |
| Feb 29, 2024 | 607,000.00 |
| Feb 29, 2024 | 607,000.00 |